• Dr. Michael Hanaway joined the UAB Division of Transplantation in February 2005. A native of Wisconsin, Dr. Hanaway received his undergraduate degree from the University of Wisconsin, and proceeded to medical school at the University of Wisconsin, graduating in 1992. He completed his surgical residency in general surgery at the University of Wisconsin in 1997, and returned after a year of research at Duke University to complete his multi-organ transplant fellowship in 2000. Dr. Hanaway began his surgical career at the University of Cincinnati before coming to UAB in 2005. Dr. Hanaway is a specialist in kidney and pancreas transplantation as well as live donor surgery. Dr. Hanaway is the Surgical Director of the Kidney Transplant Program at UAB, and oversees all aspects of the program, with particular attention to pre-transplant evaluation. Dr. Hanaway has served on UNOS committees including the Membership and Professional Standards Committee. Dr. Hanaway is reviewer for the American Journal of Transplantation, Transplantation and The American Journal of Surgery.

    Dr. Hanaway’s clinical interests include kidney and pancreas transplantation. His surgical focus is primarily on kidney transplantation and laparoscopic live donor nephrectomy. Over the past 15 years, Dr. Hanaway has performed a high volume of laparoscopic donor nephrectomies and has one of the largest experiences in the U.S. Dr. Hanaway’s research interest has focused on induction therapy in kidney transplantation.
  • Selected Publications

    Academic Article

    Year Title Altmetric
    2020 Clinical pig kidney xenotransplantation: How close are we? 2020
    2020 Enhanced Advocacy and Health Systems Training through Patient Navigation Increases Access to Living-donor Kidney Transplantation 2020
    2020 Redefining the Influence of Ethnicity on Simultaneous Kidney and Pancreas Transplantation Outcomes: A 15-year Single-center Experience 2020
    2019 Patient Perspectives on Weight Management for Living Kidney Donation 2019
    2019 Donation approval among obese living kidney donor candidates: The impact of metabolic syndrome 2019
    2019 Mitigating Racial and Sex Disparities in Access to Living Donor Kidney Transplantation: Impact of the Nation's Longest Single-center Kidney Chain 2019
    2018 Population Health, Ethnicity, and Rate of Living Donor Kidney Transplantation 2018
    2015 Preoperative arterial microcalcification and clinical outcomes of arteriovenous fistulas for hemodialysis 2015
    2013 Correlation of pre-existing vascular pathology with arteriovenous graft outcomes in hemodialysis patients 2013
    2013 Preoperative venous intimal hyperplasia, postoperative arteriovenous fistula stenosis, and clinical fistula outcomes 2013
    2011 Medial fibrosis, vascular calcification, intimal hyperplasia, and arteriovenous fistula maturation 2011
    2011 The authors reply 2011
    2011 Alemtuzumab induction in renal transplantation 2011
    2008 Incidence of adverse events with HMG-CoA reductase inhibitors in liver transplant patients 2008
    2007 Temporary silastic mesh closure for adult liver transplantation: A safe alternative for the difficult abdomen 2007
    2006 Simultaneous corticosteroid avoidance and calcineurin inhibitor minimization in renal transplantation 2006
    2005 Consequences of vancomycin-resistant Enterococcus in liver transplant recipients: A matched control study 2005
    2005 Risk for recurrence and death from preexisting cancers after transplantation 2005
    2005 Analysis of factors that influence survival with post-transplant lymphoproliferative disorder in renal transplant recipients: The Israel Penn International Transplant Tumor Registry experience 2005
    2005 United Network for Organ Sharing publication on scientific registry of transplant recipients central nervous system donor cancer transmission data [4] 2005
    2005 African-American renal transplant recipients benefit from early corticosteroid withdrawal under modern immunosuppression 2005
    2005 Laparoscopic donor nephrectomy vs. open live donor nephrectomy: A quality of life and functional study 2005
    2005 A prospective, pilot study of early corticosteroid cessation in high-immunologic-risk patients: The cincinnati experience 2005
    2005 Body weight alterations under early corticosteroid withdrawal and chronic corticosteroid therapy with modern immunosuppression 2005
    2005 Chemotherapy for posttransplant lymphoproliferative disorder: The Israel Penn International Transplant Tumor Registry Experience 2005
    2005 Corticosteroid avoidance ameliorates lymphocele formation and wound healing complications associated with sirolimus therapy 2005
    2005 De novo colorectal cancer: Five-year survival is markedly lower in transplant recipients compared with the general population 2005
    2005 Donor kidneys with small renal cell cancers: Can they be transplanted? 2005
    2005 Early corticosteroid withdrawal under modern immunosuppression in renal transplantation: Multivariate analysis of risk factors for acute rejection 2005
    2005 Early steroid withdrawal does not increase risk for recurrent focal segmental glomerulosclerosis 2005
    2005 Global cardiovascular risk under early corticosteroid cessation decreases progressively in the first year following renal transplantation 2005
    2005 Histocompatibility testing predicts acute rejection risk in early corticosteroid withdrawal regimens 2005
    2005 Laparoscopic living donor nephrectomy for kidneys with multiple arteries 2005
    2005 Laparoscopic right living donor nephrectomy 2005
    2005 Methicillin-resistant Staphylococcus aureus infection in liver transplantation: A matched controlled study 2005
    2005 Pilot study of early corticosteroid elimination after pancreas transplantation 2005
    2005 Posttransplant lymphoproliferative disorder: Significance of central nervous system involvement 2005
    2005 Prostate cancer prior to solid organ transplantation: The Israel Penn International Transplant Tumor Registry Experience 2005
    2005 Skin cancer following transplantation: The Israel Penn International Transplant Tumor Registry experience 2005
    2004 Experience with 274 cardiac transplant recipients with posttransplant lymphoproliferative disorder: A report from the Israel penn international transplant tumor registry 2004
    2004 Characteristics and survival patterns of solid organ transplant patients developing de novo colon and rectal cancer 2004
    2004 Recurrence risk after organ transplantation in patients with a history of Hodgkin disease or non-Hodgkin lymphoma 2004
    2004 Right donor nephrectomy: A comparison of hand-assisted transperitoneal and retroperitoneal laparoscopic approaches 2004
    2004 West Nile virus encephalitis in organ transplant recipients: Another high-risk group for meningoencephalitis and death? 2004
    2004 Donor transmitted malignancies. 2004
    2004 Posttransplant malignancy 2004
    2003 Donors with central nervous system malignancies: Are they truly safe? 2003
    2003 MALToma: A Helicobacter pylori-associated malignancy in transplant patients: A report from the Israel Penn International Transplant Tumor Registry with a review of published literature 2003
    2003 Maximizing renal artery length in right laparoscopic donor nephrectomy by retrocaval exposure of the aortorenal junction 2003
    2002 Hand-assisted laparoscopic living-donor nephrectomy as an alternative to traditional laparoscopic living-donor nephrectomy 2002
    2002 Incidental diagnosis of gastric cancer in transplant recipients improves patient survival 2002
    2002 De novo breast cancer in renal transplant recipients 2002
    2002 De novo sarcomas in solid organ transplant recipients 2002
    2002 Gastric cancer in transplant recipients: Detection of malignacy by aggressive endoscopy 2002
    2002 Immunosuppression and merkel cell cancer 2002
    2002 Polyomavirus in kidney and kidney-pancreas transplantation: A defined protocol for immunosuppression reduction and histologic monitoring 2002
    2002 Surgical techniques in right laparoscopic donor nephrectomy 2002
    2002 The role of immunosuppression in lymphoma. 2002
    2002 Transplantation without steroids 2002
    2001 Biologic behavior of carcinoid tumors in solid organ transplant recipients: The Israel Penn international transplant tumor registry experience 2001
    2001 Kaposi sarcoma: An analysis of the US and international experiences from the Israel Penn international transplant tumor registry 2001
    2001 Laparoscopic live donor nephrectomy: Rationale, techniques, and implications 2001
    2001 Are concerns over right laparoscopic donor nephrectomy unwarranted? 2001
    2001 Is any method of vascular control superior in hepatic resection of metastatic cancers?: Longmire clamping, pringle maneuver, and total vascular isolation 2001
    2001 Transmission of donor cancer into cardiothoracic transplant recipients 2001
    2000 The role of anti-Galα1-3Gal antibodies in acute vascular rejection and accommodation of xenografts 2000
    2000 Long-term results of liver transplantation in patients 60 years of age and older 2000
    1998 The promise of xenografting 1998
    1997 Split tolerance induced by immunotoxin in a rhesus kidney allograft model 1997
    1997 FN18-CRM9 immunotoxin promotes tolerance in primate renal allografts 1997
    1996 Immunosuppressive effects of an HLA class I-derived peptide in a rat cardiac allograft model 1996


    Year Title Altmetric
    2005 Transplant-Related Malignancies.  1149-1164. 2005

    Research Overview

  • induction therapy in kidney transplantation
  • Principal Investigator On

  • Private Grant  awarded by TRANSPLANT INFORMATICS INSTITUTE 2008 - 2011
  • Investigator On

  • APOL1 Long-Term Kidney Transplantation Outcomes Network (APOLLO) Clinical Center  awarded by National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS 2019 - 2022
  • Private Grant  awarded by ASTELLAS PHARMA US, INC. 2017 - 2021
  • Private Grant  awarded by PROTEON THERAPEUTICS, INC. 2016 - 2021
  • Effects of Inhibiting Early Inflammation in Kidney Transplant Patients  awarded by ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI 2019 - 2020
  • HOPE in Action: A Clinical Trial of HIV-to-HIV Deceased Donor Kidney Transplantation  awarded by Johns Hopkins University 2018 - 2020
  • Impact of CCR5 Blockade in HIV + Kidney Transplant Recipients  awarded by University of California, San Francisco 2016 - 2020
  • Private Grant  awarded by ASTELLAS PHARMA GLOBAL DEVELOPMENT, INC. - NEW 2018 - 2019
  • Effects of Inhibiting Early Inflammation in Kidney Transplant Patients - Equipment  awarded by Mount Sinai School of Medicine 2015 - 2019
  • Private Grant  awarded by QUARK PHARMACEUTICALS, INC. 2015 - 2019
  • Private Grant  awarded by NOVARTIS PHARMACEUTICALS CORPORATION 2015 - 2018
  • Private Grant  awarded by PROTEON THERAPEUTICS, INC. 2014 - 2018
  • Private Grant  awarded by ASTELLAS PHARMA US, INC. 2013 - 2017
  • Private Grant  awarded by ALEXION PHARMACEUTICALS, INC. 2014 - 2017
  • Preserving Renal Function & Protective Immunity via Anti-LFA-1-Based CNI Avoidance  awarded by Emory University 2009 - 2016
  • Private Grant  awarded by ALEXION PHARMACEUTICALS, INC. 2013 - 2016
  • Optimizing Kidney Transplant Patients' Informed Consent for Increased Risk Donors  awarded by Northwestern University 2012 - 2014
  • Education And Training

  • Doctor of Medicine, University of Wisconsin System : Madison 1991
  • University of Wisconsin Hospital & Clinics, Internship 1992
  • University of Wisconsin Hospital & Clinics, Residency 1997
  • University of Wisconsin Hospital & Clinics, Postdoctoral Fellowship 2000
  • Full Name

  • Michael Hanaway